[Psychic manifestations during treatment of Parkinson's disease with L-dopa].
D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy
D004295:Dihydroxyphenylalanine
A propos des manifestations psychiques au cours des traitements des syndromes parkinsoniens par la L-dopa.